Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

407.83 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

69 70 Next >

Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket ↗

May 12, 2025

What Happened: On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the "most consequential executive order" in U.S. history, aimed at lowering prescription...

Via Benzinga

Topics Government

Thursday's session: gap up and gap down stock in the S&P500 index ↗

May 08, 2025

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

2 Unstoppable Dividend Stocks to Buy and Hold Forever ↗

May 08, 2025

Via The Motley Fool

Topics Intellectual Property

What the Options Market Tells Us About Amgen ↗

May 07, 2025

Via Benzinga

Amgen Unusual Options Activity For May 02 ↗

May 02, 2025

Via Benzinga

Earnings Scheduled For May 1, 2025 ↗

May 01, 2025

Via Benzinga

Is the Market Bullish or Bearish on Amgen? ↗

April 23, 2025

Via Benzinga

Chinese Biotech BeiGene Stock Falls Despite Strong Brukinsa Sales And Earnings Beat ↗

May 07, 2025

BeiGene posted a surprise Q1 profit and $1.12 billion in revenue, with strong U.S. Brukinsa sales, while reaffirming its 2025 outlook and margin guidance.

Via Benzinga

Forecasting The Future: 7 Analyst Projections For Amgen ↗

May 07, 2025

Via Benzinga

Amgen's Better Than Expected Q1 Earnings Take Backseat As Eyes Are On MariTide Obesity Data ↗

May 02, 2025

Analysts highlight MariTide's upcoming updates and near-term catalysts, while Amgen's price targets shift amid steady outlook and investor caution.

Via Benzinga

Nasdaq 100 Leads Wall Street Rally As China Signals Openness To Fentanyl Talks, Easing Trade Tensions ↗

May 02, 2025

U.S. stocks rose on hopes of China's willingness to negotiate a trade deal regarding fentanyl production. Tech stocks led the rally.

Via Benzinga

Wall Street Eyes 9th Straight Day Of Gains, Apple Falls As Chinese Sales Disappoint: What's Driving Markets Friday? ↗

May 02, 2025

U.S. stocks advanced across the board by midday Friday, with the S&P 500 eyeing its ninth consecutive day of gains—poised for the longest winning streak since May 2024.

Via Benzinga

3 Biotech Giants Gaining From U.S. Sales and Policy Shifts

May 02, 2025

The significant domestic revenue base of select US biotech companies offers stability potential for investors navigating global trade complexities.

Via MarketBeat

Topics Economy World Trade

Amgen’s (NASDAQ:AMGN) Q1: Beats On Revenue

May 01, 2025

Biotech company Amgen (NASDAQ:AMGN) announced better-than-expected revenue in Q1 CY2025, with sales up 9.4% year on year to $8.15 billion. The company expects the full year’s revenue to be around $35...

Via StockStory

Wall Street Eyes 8th Positive Day As S&P 500 Recoups Tariff-Led Losses, Bitcoin Rallies To $97,000: What's Driving Markets Thursday? ↗

May 01, 2025

Wall Street pushed higher in midday trading, with the S&P 500 on track for its eighth consecutive gain — its longest winning streak since November 2023. The index rose about 1% to 5,560, fully...

Via Benzinga

Topics Government Stocks World Trade

Beat the Nasdaq With This Cash-Gushing Dividend Stock ↗

May 01, 2025

Via The Motley Fool

Topics Economy Stocks

Looking At Amgen's Recent Unusual Options Activity ↗

April 30, 2025

Via Benzinga

These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount ↗

April 30, 2025

Via The Motley Fool

Amgen (AMGN) Reports Earnings Tomorrow: What To Expect

April 30, 2025

Biotech company Amgen (NASDAQ:AMGN) will be reporting earnings tomorrow afternoon. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence Economy World Trade

Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom ↗

April 28, 2025

Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...

Via Talk Markets

Topics ETFs Stocks / Equities

The Week Ahead: PCE Inflation Data And Big Tech Earnings In Focus ↗

April 27, 2025

Markets brace for crucial week with Big Tech earnings, Trump's 100-day milestone, and key economic data as trade concerns linger.

Via Talk Markets

Topics Economy Government Stocks / Equities

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off ↗

April 26, 2025

Via The Motley Fool

Topics Economy Intellectual Property World Trade

1 Value Stock to Research Further and 2 to Ignore

April 24, 2025

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are...

Via StockStory

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold ↗

April 22, 2025

Via The Motley Fool

Topics Government

Amgen, Franco-Nevada, Take-Two Interactive And More: CNBC's 'Final Trades' ↗

April 22, 2025

Via Benzinga

Short Week Finishes With Netflix Q1 Beat ↗

April 18, 2025

Considering the blue-chip Dow face-planted ahead of the open on a disappointing Q1 report from UnitedHealth, which resulted in a -22% tanking by Thursday’s close, this was a pretty flat day.

Via Talk Markets

Topics Stocks Stocks / Equities

Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React ↗

April 17, 2025

Lilly's weight-loss drug trial shows promising results, propelling stock up 14.36%. Goldman Sachs predicts potential $23.5B in sales by 2035.

Via Benzinga

2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever ↗

April 17, 2025

Via The Motley Fool

Topics Government World Trade

Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks

April 16, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie...

Via StockStory

Topics Artificial Intelligence

Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug ↗

April 14, 2025

Sandoz sues Amgen in U.S. court over Enbrel patents, alleging efforts to block biosimilar Erelzi and delay competition in the inflammatory disease market.

Via Benzinga

Topics Intellectual Property Lawsuit

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.